US: Meeting Held to Discuss Delay of Banning Menthol Cigarettes

Regulations by 2FIRSTS.ai
Dec.21.2023
US: Meeting Held to Discuss Delay of Banning Menthol Cigarettes
US government officials and public health leaders held a meeting to discuss the delayed ban on menthol cigarettes.

According to a report by thehill, there has been a recent meeting between US government officials and public health leaders. This meeting took place following the US government's decision to delay the ban on flavored menthol cigarettes.

 

The meeting, which was not publicly announced, was not officially included in the public agenda. However, government officials had previously held a meeting with tobacco industry lobbyists, including some former senators, last month, in opposition to the proposed ban. Two weeks later, the White House officially announced that the ban would be postponed until at least March.

 

The online conference held this Tuesday, initiated by the "Smoke-Free Youth" campaign, was attended by officials including Robert Califf, the Commissioner of the U.S. Food and Drug Administration (FDA), Xavier Becerra, the Secretary of Health and Human Services (HHS), and Neera Tanden, the White House Domestic Policy Advisor.

 

According to feedback from attendees, the organization of the meeting took place after the announcement of the delay in the ban, during which public health officials questioned industry lobbyists on the reasons behind their ability to meet with senior government officials.

 

In attendance among public health and civil rights leaders were Derrick Johnson, President and CEO of the National Association for the Advancement of Colored People (NAACP); David Satcher, former advocate for disease prevention and the first African American Surgeon General of the United States; Louis Sullivan, former Secretary of the U.S. Department of Health and Human Services (HHS); Yolanda Lawson, Chair of the American Medical Association; as well as board leaders from the American Cancer Society Cancer Action Network, the American Lung Association, and the American Heart Association.

 

The Office of Management and Budget (OMB), which is responsible for regulatory actions, needs to hold meetings with stakeholders interested in the proposed regulations. These meetings are held to gather opinions and are typically not attended by senior officials.

 

Since October, the OMB has held multiple meetings with external organizations regarding policies, including retailers, civil rights groups, and law enforcement officials. According to records, nearly all of the meetings have been with organizations opposed to the ban.

 

The public health organization has been warning that the White House may under pressure decide to indefinitely delay the regulation, especially against the backdrop of Joe Biden's reelection bid as president.

 

According to the initially planned schedule, the new regulations were supposed to be released in August, but were later postponed until the end of the year. As part of its regulatory plan, the White House has now set a new target date for March 2024.

 

The ban on menthol cigarettes has been under consideration for more than a decade and, once implemented, will be one of the most impactful policies since the US FDA began regulating tobacco in 2009. Health officials and tobacco control advocates have stated that this action could potentially save thousands of lives, particularly among African American smokers.

 

According to an FDA report, approximately 85% of African American smokers prefer menthol cigarettes, compared to only 30% among white smokers.

 

However, the proposal of the ban has sparked disagreement among some influential black lawmakers and community members. Critics argue that this foreshadows a longstanding industry practice aimed at targeting black communities and forming alliances with leaders to create chaos.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Smoore's Subsidiary CCELL Faces Antitrust Lawsuit in the U.S., Accused of Price Manipulation and Market Monopoly
Smoore's Subsidiary CCELL Faces Antitrust Lawsuit in the U.S., Accused of Price Manipulation and Market Monopoly
A U.S. federal court in Arizona has recently accepted a class-action lawsuit against Chinese e-cigarette manufacturer Smoore and its U.S. distributor. The suit accuses them of monopolizing the U.S. cannabis vape market through price manipulation and market division, resulting in higher costs for consumers. This marks the second such case filed this year.
Jul.03 by 2FIRSTS.ai
Smoore's 2025 first-half performance: Revenue rose 18.3% to 6.013 billion yuan, with self - brand revenue up 14.1% to 1.274 billion yuan
Smoore's 2025 first-half performance: Revenue rose 18.3% to 6.013 billion yuan, with self - brand revenue up 14.1% to 1.274 billion yuan
In the first half of 2025, Smoore's revenue reached 6.013 billion yuan, up by 18.3%. The adjusted net profit was 737 million yuan, down by 2.1%. The ToB business revenue was 4.739 billion yuan, up by 19.5%, while the self - brand business revenue was 1.274 billion yuan, up by 14.1%.
Aug.21 by 2FIRSTS.ai
South Korea Holds 2nd Local Community Smoke-Free Policy Workshop, Emphasizes Importance of Strengthening E-Cigarette Regulations
South Korea Holds 2nd Local Community Smoke-Free Policy Workshop, Emphasizes Importance of Strengthening E-Cigarette Regulations
Gyeonggi-do Provincial Council of South Korea Holds Seminar, Emphasizing Stricter E-Cigarette Regulation and Revised Rules to Protect Students' Health.
Aug.26 by 2FIRSTS.ai
KT&G Subsidiary Faces Facility Investment Dilemma as Capacity Expansion Outpaces Weak Order Demand
KT&G Subsidiary Faces Facility Investment Dilemma as Capacity Expansion Outpaces Weak Order Demand
KT&G subsidiary Taeya Industry booked heavy impairment losses after overinvesting in capacity based on inaccurate demand forecasts. Although KT&G aims to offset the damage through global value-chain expansion, Taeya’s financial health remains severely strained, and the company is now devising new export programs to utilize its idle facilities.
Jul.15 by 2FIRSTS.ai
Caixin Reports: Yiling’s Atomizer Sparks Public Concern as Experts Call for Stronger Oversight
Caixin Reports: Yiling’s Atomizer Sparks Public Concern as Experts Call for Stronger Oversight
Caixin reports that a Yiling Pharmaceutical subsidiary’s atomizer, resembling an e-cigarette, has sparked public concern. Experts classify herbal atomizers as e-cigarettes and call for stricter oversight. China’s tobacco regulator has confirmed such products fall under e-cigarette rules and pledged to maintain strict enforcement.
Jul.31
Scotland E-Cigarette Market Report (1): Vape sales Drop by 33% Year-on-Year, 2ml Pod Share Rises to 38.4%
Scotland E-Cigarette Market Report (1): Vape sales Drop by 33% Year-on-Year, 2ml Pod Share Rises to 38.4%
Data shows a shift as disposable products decline, with 2ml pods rising to 38.4%. Larger devices and multi-use kits are emerging, driven by promotions. However, illegal disposables persist, and regulatory gaps remain. Talysis reports that the market is transitioning to compliant alternatives.
Aug.06 by 2FIRSTS.ai